The SPA2 protein of yeast localizes to sites of cell growth by unknown
The SPA2 Protein of Yeast Localizes 
to Sites of Cell Growth 
Michael Snyder 
Department of Biology, Yale University, New Haven, Connecticut 06511 
Abstract.  A  yeast gene, SPA2, was isolated with hu- 
man anti-spindle pole autoantibodies. The SPA2 gene 
was fused to the Escherichia  coli trpE gene, and poly- 
clonal antibodies were prepared to the fusion protein. 
Immunofluorescence experiments indicate that the 
SPA2 gene product has a  sharply polarized distribution 
in yeast cells. In budded cells the SPA2 protein is 
present at the tip of the bud;  in unbudded cells, it is 
localized to one edge of the cell. When a-cells are in- 
duced to form schmoos with a-factor, the SPA2 pro- 
tein is found at the tip of the schmoo. These areas of 
SPA2 localization correspond to cellular sites expected 
to be involved in bud formation and/or cell growth. 
The SPA2 antigen is present in a-cells, a-cells,  and 
a/a-diploid cells, but is absent in mutant cells in 
which the SPA2 gene has been disrupted, spa2  mutant 
cells are viable, but display defects in the direction 
and control of cell growth. Compared to wild-type 
cells, spa2  mutant cells have slightly altered budding 
patterns.  Entry into stationary phase is impaired for 
spa2  mutants, and mutants with one particular allele, 
spa2-7,  form multiple buds under nutrient-limiting 
conditions. Thus, SPA2 is a  newly identified yeast 
gene that is involved in the direction and control of 
cell division, and whose gene product localizes to the 
site of cell growth. 
T 
HE generation and maintenance of cell polarity is a 
process pertinent to most eukaryotes. Cellular mor- 
phogenesis of many cell types depends on polarized 
cell growth, and the development and differentiation of mul- 
ticellular organisms requires  accurate polarized cell divi- 
sions at crucial times in development. Little is known about 
the molecules that specifically reside in regions of cell gr0wth 
or the molecular mechanisms that govern polarized growth 
and division. 
The  budding yeast,  Saccharomyces cerevisiae, exhibits 
polarized cell growth. In late G1 of  the cell cycle, bud synthe- 
sis initiates at a site on the edge of the cell. Bud growth con- 
tinues principally at the bud tip until the size of the bud nears 
that of the mother cell (Byers,  1981; Adams and Pringle, 
1984).  Cytological observations suggest that microtubules 
may play an important role in bud formation and/or growth. 
In budded cells, cytoplasmic microtubules extend into the 
bud. In unbudded G1 cells, cytoplasmic microtubules ema- 
nate from the yeast spindle pole body and have been postu- 
lated  to  direct  the  site  of bud  formation (see  Byers and 
Goetsch, 1975; Byers, 1981). A full complement of microtu- 
bules is not essential for bud formation because tubulin mu- 
tants and nocodazole-treated cells are still able to form buds 
(Huffaker et al., 1988; Jacobs et al., 1988). However, micro- 
tubules may still play an important role either in directing 
bud site formation and/or in augmenting cell growth. 
S. cerevisiae is also useful for studying polarized cell divi- 
sion because yeast controls the directionality of each cell di- 
vision. The pattern of bud formation occurs in a well-defined 
fashion depending upon the mating type and pedigree of the 
cell (Freifelder, 1960).  Haploid a- and a-cells bud in an ax- 
ial fashion, in which the new bud forms adjacent to the old 
bud site (Fig. 1). For diploid a/a-cells, the pattern of  budding 
is dependent upon the pedigree of the cell involved.  Mother 
cells, i.e., cells that have given birth to one or more cells, 
bud  in  an  axial pattern  similar to  that of haploids.  New 
daughter cells, however, bud in a polar fashion, with the new 
bud  forming opposite  the  old  birth  scar.  The  molecular 
mechanism that determines cell polarity is not understood at 
present. 
The decision to initiate cell growth is made in late G1 of 
the cell cycle, at a point called Start (Hartwell, 1974). Once 
cells have completed Start they are committed to progress 
through the remainder of the cell cycle. This commitment is 
dependent on a variety of factors (reviewed in Pringle and 
Hartwell,  1981). Among the factors are both positive and 
negative signals. First, cells must reach a critical size; cells 
that are too small will not enter the mitotic cell cycle.  Sec- 
ond, when nutrients are limiting, cells will arrest and enter 
stationary phase. Alternatively, when particular nutrients are 
limiting, diploid cells can also exit the mitotic cell cycle and 
begin sporulation. Finally, in the presence of mating hor- 
mones, haploid cells of the opposite mating type will also ar- 
rest before Start. 
In this paper a yeast gene is described called SPA2 (for 
I.  Abbreviations used in this paper:  cMor, centiMorgans; fl-gal, fl-galac- 
tosidase; SPA,  spindle pole antigen. 
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Figure  1.  Budding  patterns  of haploid  and  diploid  yeast  cells. 
Haploid mother (M) and daughter (DI) cells form new buds (D2 
and D1.1, respectively) adjacent to the old bud site. Diploid mother 
cells  exhibit  the  same  pattern  as  haploid  mothers,  but  diploid 
daughter cells bud opposite the old bud site. 
Spindle Pole Antigen) that is important for cell growth and 
bud formation. The SPA2 gene product localizes to the site 
of  cell growth, and mutations in the SPA2 gene lead to defects 
in both the control and the direction of cell division. 
Materials and Methods 
Yeast Strains~General Methods 
All yeast strains are in an isogenic $288c background; a list is presented 
in Table I. YPD media and general genetic manipulations are as described 
in Sherman et al. (1986).  General cloning ~rocedures are as described in 
Davis et al. (1980),  Maniatis et al. (1982),  and Snyder and Davis (1988). 
Isolation and Disruption of the SPA2 Gene 
The SPA2  gene was isolated by immunoscreening a yeast genomic DNA ex- 
pression library with the 5051 anti-spindle pole autoantibody (Tuffanelli et 
al., 1983) as described in Snyder and Davis (1988).  Transplason mutagene- 
sis of XSPA2.2 with mini-Tnl0 transposons containing the URA3 gene is 
detailed in Snyder et al. (1986).  Substitution of the mutated SPA2 gene for 
the genomic copy was accomplished  by one step gene transplacement (Roth- 
stein, 1983). 2 #g ofa minipreparation of mutagenized phage DNA (Snyder 
et al., 1986) was partially digested with Eco RI and transformed into diploid 
yeast strain Y270 using the lithium acetate procedure of Ito et al. {1983). 
The resulting transformants were sporulated and substitution at the SPA2 lo- 
cus was checked in haploid progeny by genomic DNA gel blot analysis using 
SPA2 gene probes. Crosses of Ura  +  spa2-7 and spa2-8 mutant cells with 
other Ura  ÷  spa2-7and spa2-8 mutant cells always showed 4:0 segregation 
of the URA3 marker. 
The spa2-Al allele was constructed by cloning a 7.4-kb Sal I/Kpn I DNA 
fragment containing the SPA2 gene into a yeast centromeric plasmid that 
contains a  TRP1 gene. The  resulting plasmid is called p188.  A  1.4  kb 
TRP1/ARS1 Eco RI fragment of YRp7 was subsequently substituted for the 
internal 2.2-kb Sph I fragment of the SPA2 gene. To perform this last step, 
the ends of the TRP1/ARS1 fragment and the appropriate p188 fragment had 
first been  made flush using  the  large  fragment of DNA  polymerase I. 
Diploid yeast cells were transformed with a linear DNA fragment contain- 
ing the spa2-A1 allele and sporulated. Substitution at the SPA2 locus was 
confirmed in haploid progeny by three criteria: (a) genomic gel blot analysis 
and tetrad analysis as described above, (b) by the failure of spa2-A 1 mutant 
cells to stain with anti-SPA2 antibodies using indirect immunofluorescence, 
and (c) by the failure of  proteins from spa2 mutant cells to react with affinity- 
purified anti-SPA2 antibodies using immunoblot analysis. 
Production of  Antibodies to the SPA2 Protein 
A 1.9-kb Sca I fragment derived from M0 (Fig. 2) was cloned into the Sma 
I site of pATH11 and introduced into Escherichia coli strain CAG456 (Baker 
et al.,  1984).  An overnight culture of this strain was grown in M9 media 
containing 50 ttg/ml ampicillin and 20 p,g/ml tryptophan.  Four cultures 
were prepared that contained 2.5 ml of the fresh overnight culture diluted 
into 110 ml of M9 media (lacking ampicillin and tryptophan) in a 2 liter 
flask, and the cultures were grown for 3-4 h at 30°C. Expression of the fu- 
sion protein was induced by the addition of 1.5 ml of 1 mg/ml indoleacrylic 
acid to each flask, and the incubation was continued for 4 h more at 30°C. 
Cells were next incubated at 4°C for 2-10 h, then pelleted at 7,500 g for 
3 min, and washed once with 20 ml 50 mM Tris-HCl, pH 7.5, 5 mM EDTA 
(solution A). The cell pellet was resuspended in 20 ml solution A containing 
3 mg/ml lysozyme and incubated on ice for 2-3 h.  1.4 ml 5 M NaCI and 
1.5 ml of 10% NP-40 were added, and after 30 min the sample was sonicated 
briefly to lyse the cells. The insoluble material was collected by centrifuga- 
tion at 12,000 g for 10 min at 0°C, and the pellet washed twice with 20 ml 
10 mM Tris-HC1, pH 7.5, followed by 12,000 g centrifugation as above after 
each  wash.  The  final  pellet  was  dissolved in  0.8  ml  SDS  lysis buffer 
(Laemmli, 1970). 0.5-2 mg of SPA2/trpE fusion protein was recovered per 
Table L  Strain list 
$288c  isogenic background 
Y90  a ura3-52  lys2-801  ade2-101  trpl-901 
Y93  aura3-52  lys2-801  ade2-101  trpl-901  his3-A200 
Y216  a ura3-52  1ys2-801 ade2-101  trpl-901  spal-1/TRP1 
Y197  a urn3-52  lys2-801  ade2-101  trpl-901  his3-A200 
Y415  aura3-52  lys2-801  ade2-101  trpl-901  his3-A200 
Y416  aura3-52  lys2-801  ade2-101  trpl-901  his3-A200 
Y420  a urn3-52  lys2-801  ade2-101  trpl-901  his3-A200 
Y421  ce ura3-52  lys2-801  ade2-101  trpl-901  his3-A200 
Y548  aura3-52  lys2-801  ade2-101  trpl-901  his3-A200 
Y549  ce urn3-52  lys2-801  ade2-101  trpl-901  his3-A200 
Y550  oe urn3-52  lys2-801  ade2-101  trpl-901  his3-4200 
Y551  aura3-52  lys2-801  ade2-101  trpl-901  his3-A200 
Y270  (YNN318)  a urn3-52  lys2-801  ade2-101  trpl-901  his3-A200 
ce urn3-52 
Y376  a urn3-52 
ct ura3-52 
Y457  a urn3-52 
ct urn3-52 
Y556  a urn3-52 
ce ura3-52 
lys2-80t  ade2-101  trpl-901  his3-A200 
lys2-801  ade2-101  trpl-901  his3-A200 
lys2-801  ade2-101  trp  l- 901  HIS3 
lys2-801  ade2-101  trpl-901  his3-A200 
lys2-801  ade2-101  trpl-901  his3-A200 
lys2-801  ade2-lO1  trpl-901  his3-A200 
lys2-801  ade2-101  trpl-901  his3-A200 
spal-2/URA3 
spa2- 7/URA3 
spa2  - 7/URA3 
spa2-8/URA3 
spa2-8/URA3 
spa2-A1/TRP1 
spa2-A1/TRP1 
spa1-1 
spa1-1 
spa2- 7/URA3 
spa2- 7/URA3 
spa2-  A1/TRP1 
spa2-A 1/TRPI 
The strains  Y548-Y551  are the progeny  of a single meiosis. 
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Figure 2. Restriction map of the SPA2 locus. The SPA2 open reading 
frame is indicated by the open box; the extent of the open reading 
frame is crudely estimated from protein gel data and the positions 
of the endpoints are  imprecise (see Discussion).  Restriction en- 
donuclease sites are also indicated on the map; Sca I sites were not 
mapped outside of the SPA2 open reading frame. The extent of the 
SPA2kgtl 1- and XEMBL3A-cloned DNA inserts are shown beneath 
the map. The 1.9-kb Sea I fragment was inserted into the pATHll 
vector which allowed the production of a  107-kD SPA2/trpE fusion 
protein. 
u-factor (3 #g/ml final concentration) to a culture grown in YPD media to 
OD (600) '~0.5. 50 min later u-factor treatment was repeated, and after an 
additional 40 min cells were fixed for immunofluorescence. For immunoflu- 
orescence on mating cells, a-cells grown to OD (600) ,'~0.5 were mixed with 
u-cells grown to the same density, and harvested 5 h later. 
Polarity of  Budding 
The budding pattern of yeast cells was determined by isolating individual 
budded cells from an exponentially growing culture, aligning them on a 
YPD plate by micromanipulation, and inspecting the cells every 5-15 min 
through a dissecting microscope. These experiments were carried out at 
24°C. After the mother cell and the daughter cell had budded, the cells were 
separated, and the observation continued. The position of the new bud was 
determined relative to the old bud. Deviations from the axial budding pat- 
tern of mother cells, particularly in diploids, were observed when using ei- 
ther (a) random cells from a growing population, or (b) cells starting growth 
from stationary phase, or (c) cells in which the mother cell had already un- 
dergone several divisions.  Therefore,  the  results  of budding  from new 
mother cells and daughter cells are presented below and were quite repro- 
ducible. For haploid daughter cells in our strains, the direction of budding 
can sometimes be difficult to determine because the mother cell usually has 
budded twice before the time the daughter buds.  The extra buds of the 
mother can perturb the orientation of  daughter cell, thereby creating scoring 
inaccuracies for daughter budding patterns. For diploids, the mother cell 
only buds once before the daughter buds and the interference is minimal. 
liter of culture.  The  fusion protein was  electroeluted from preparative 
SDS-7% polyacrylamide gels (Laemmli, 1970) and precipitated with ace- 
tone. 200/zg was injected into a rabbit with boost injections every 3-6 wk. 
The titer of the serum was monitored with immunoblots (Burnette, 1981) 
containing  SPAI/trpE,  SPA2/trpE,  SPA1//~-galactosidase  (/%gal),  SPA2/ 
fl-gal, B-gal, and trpE proteins. SPA1/~-gal and SPA2/fl-gal  fusion proteins 
were prepared from XSPAI.I and KSPA2.3 clones (Snyder and Davis, 1988) 
using E. coli strain CAG456 and previously described procedures (Snyder 
et al., 1987).  Affinity-purified  antibodies to the SPA2 protein were prepared 
by incubating 200-250 #g of SPA2/trpE fusion protein with a 1.7-cm  2 piece 
of nitrocellulose overnight at 4°C. The filter was washed with TBS (150 mM 
NaCI, 50 mM Tris-HCl) and incubated with TBS containing 3 % BSA for 
2 h. The filter was next incubated overnight at 4°C with rabbit serum (0.4 
ml diluted with 0.8 ml TBS), and the filter was subsequently washed five 
to six times with TBS. Bound antibody was eluted with a 0.2 M glycine solu- 
tion, pH 2.5, neutralized as described (Snyder et al.,  1987),  and dialyzed 
against TBS for 8 h. 1:100 dilutions in TBS plus 1% BSA were used for im- 
munofluorescence, and  1:300 dilutions in TBS plus 20%  fetal calf serum 
were used for immunoblots. 
Yeast Immunoblot Analysis 
Total yeast cellular proteins were prepared as follows: haploid yeast cultures 
were grown in 5 rrd YPD to OD (600) ,x,1, collected by centrifugation, and 
washed once with distilled water. Cells were resuspended in 50 #i double 
distilled H20 and 0.5 ml SDS lysis buffer was added. (SDS lysis buffer = 
40 mM Tris-HCl [pH6.8],  1% SDS, 50 mM dithiothreitol, 50% wt/vol urea, 
and 2 #g/ml each of chymostatin, leupeptin, antipain, and pepstatin.) 0.4 
ml of acid-washed glass beads were added, and the sample was vortexed at 
high speed for 5-10 min. The sample was next heated at 105°C for 2 min, 
centrifuged for 5 min at 13,000 g, and 5 ~tl was loaded onto a 5-16% poty- 
acrylamide-SDS gel (Laemmli, 1970).  The integrity of  the protein prepara- 
tion and the relative amount of protein for each sample was accessed by 
comparing the different lanes after staining the gel with Coomassie blue. 
Immunoblots were prepared and probed with afffinity-purified anti-SPA2 an- 
tibodies as described (Snyder and Davis,  1988). 
Immunofluorescence 
Indirect immunofluorescence using fixed yeast cells was performed as de- 
scribed in Kilmartin and Adams (1984),  Adams and Pringle (1984),  and 
Bond et al.  (1986).  A human anti-microtubule autoantiserum that reacts 
with mitotic spindles of yeast and mammalian cells was used in the double 
immunofluorescence experiments. Bound rabbit antibodies were detected 
with affinity-purified, fluorescein-conjugated goat anti-rabbit antibodies; 
bound human antibodies were identified with affinity-purified rhodamine- 
conjugated goat anti-human antibodies, a-Cells were arrested by adding 
Results 
Identification  of the SPA2 Gene 
The SPA2 gene ofS. cerevisiae was identified during a search 
for  yeast  genes  related  to  the  mammalian  spindle  pole 
(Snyder and Davis,  1988). A  kgtll  yeast genomic DNA ex- 
pression library was screened with human anti-spindle pole 
autoantibodies, and three 3,gtl 1 SPA2 clones were identified 
and characterized  (Fig.  2).  The kgtll  clones  LSPA2.3 and 
kSPA2.4 encode large fl-gal fusion proteins, estimated to be 
>250 kD, of which 114 kD is fl-gal (Fig. 3 A). Thus, the SPA2 
gene contains a long open reading frame. Proteins encoded 
by XSPA2.3 can be used to affinity purify antibodies from a 
human anti-spindle pole antiserum.  These affinity-purified 
antibodies  recognize  the  mammalian  spindle  pole  by  im- 
munofluorescence, demonstrating that the SPA2 protein has 
epitopes  in  common  with  the  mammalian  spindle  pole 
(Snyder and Davis,  1988). 
The SPA2 Gene Maps to Chromosome XII 
Gel blot analysis of genomic DNA has indicated that SPA2 
is  a  single  copy  gene  in yeast  (Snyder and Davis,  1988). 
Resolution of yeast chromosomal DNA by pulsed-field gel 
electrophoresis followed by hybridization with SPA2 DNA 
probes mapped the SPA2 gene to chromosome XII (Snyder 
and Davis, 1988). Initial genetic crosses indicated that SPA2 
is linked to a centromere. We therefore tested whether SPA2 
is linked to ASP5, which is known to reside close to the cen- 
tromere on chromosome XII. A spa2 mutant gene containing 
a URA3 marker (see below) was genetically mapped relative 
to asp5 using standard tetrad analysis (Sherman et al., 1986; 
Table II). In the same crosses, the position of the SPA2 gene 
was  mapped  relative to  the  centromere using  the  met14 
marker. From this analysis, spa2 was found to lie ,035 cen- 
tiMorgans (cMor) from asp5 and 21 cMor from the centro- 
mere. ASP5 was determined to be 21 cMor from the centro- 
mere, in reasonable agreement with published results (18.2 
cMor; Mortimer and Schild, 1980). Thus, we conclude that 
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teins  of  SPAI and  SPA2 hgtll 
clones.  E.  coli lysates  contain- 
ing/3-gal  fusions were prepared 
from hSPA2.3 and XSPAI.1 as de- 
scribed  in  Snyder et  al.  (1987). 
Approximately 30, 20, and 10/~g 
of protein lysates of each sample 
were loaded  (from left to  right) 
and  separated on 5%  polyacryl- 
amide-SDS gels (Laemmli, 1970), 
and the gel stained with Coomas- 
sie blue.  The estimated  sizes of 
the fusion proteins is indicated on 
the right; 114, the migration posi- 
tion  of the  /8-gal marker.  Iden- 
tification of the  SPAI  and  SPA2 
fusion proteins was confirmed by 
preparing immunoblots of a simi- 
lar  gel  and  probing  with  5051 
anti-spindle pole autoantibodies. 
The indicated bands react strong- 
ly with the  antiserum.  (B) trpE 
fusion  proteins.  SPA2/trpE  and 
SPA1/trpE  fusion proteins were prepared as described in Materials and Methods,  separated on a 5%  polyacrylamide-SDS gel, and the 
gel was stained  with Coomassie blue.  The samples for SPA2 are as follows:  Crude, SPA2/trpE-insoluble protein preparation; Pur, two 
gel-purified SPA2/trpE protein preparations. The sample on the left is slightly  contaminated with E. coli RNA polymerase and has not 
been used further. SPA1 samples are as follows: Pur, gel-purified SPAI/trpE protein; Crude, crude SPAl/trpE-insoluble protein preparation. 
(C) Immunoblots of SPA2//3-gal fusion proteins. Crude lysates of SPA2//3-gal and SPA1/B-gal fusion proteins were prepared using hSPA2.3 
and XSPAI.1 clones, respectively, and immunobiots of these proteins probed with SPA2 antibodies. Equal amounts of proteins are on each 
blot.  (SPA2) Protein  lysates of SPA2//3-gal  fusions probed with  preimmune  serum (Pre), immune serum (lmm), and  affinity-purified 
anti-SPA2 antibodies (AP). Extensive degradation of the SPA2//3-gal fusion proteins occurs in E. coli, hence many smaller bands exist. 
(SPA1) Protein lysates of SPAI//3-gal fusion protein probed with affinity-purified  anti-SPA2 antibodies.  The anti-SPA2 antibodies do not 
cross-react with the SPA1/~-gal protein, hence the immunoblot with the SPAI/~-gal fusion serves as a negative control for these experiments. 
SPA2 lies on the left side of chromosome XII, and the order 
of the genes  is SPA2-CENXII-ASP5. 
The SPA2 Gene Encodes a Large Polypeptide 
To investigate the function of SPA2, antibodies  were raised 
to the SPA2 gene product to.allow immunolocalization of this 
Table II.  Distance of spa2 Relative  to asp5 and the 
Centromere Marker met14 
Mar~rs  PD  NPD  TT  FDS  SDS  cMor 
spa2/URA3-asp5  12  0  29  -  -  35 
spa2/URA3-metl4  -  -  -  22  20 
spa2/URA3-CENXII  21 
asp5-metl4  -  -  -  24  23 
asp  5-CENXI1  21 
Diploid strain  Y415  x  Y487  which  is heterozygous  for asp5, met14, and 
spa2-7  (marked by URA3)  was sporulated and the segregation pattern analyzed 
in tetrads containing 4:0 and 3:1 viable/dead spores. For the three spore-viable 
tetrads, the genotype of the missing spore was deduced assuming a 2:2 segrega- 
tion pattern of the markers. Similar results were obtained for four- and three- 
spore viable tetrads. The aspS-spa2 distance was calculated using the formula 
1/2  tetratypes/total n  of tetrads  x  100  (Mortimer  and  Schild,  1980).  The 
spa2-CENXII and asp5-CENXII distances were  calculated using the metl4 
marker and the formula 1/2 second division segregation (SDS)/total number of 
tetrads ×  100, and subtracting the published distance ofmetl4 from the centro- 
mere (2.6 cM;  Mortimer and Schild,  1980).  The  strain also carries a  50-kb 
minichromosome  containing  TRPI; analysis  of  the  TRP1 marker  yielded 
results comparable to those with the metl4 data reported  in the Table.  PD, 
parental ditype; NPD,  nonparental ditype; TT,  tetratype; FDS,  first division 
segregation; SDS,  second division segregation; cMor,  centiMorgans. 
protein in yeast. A  1.9-kb open reading frame segment of the 
SPA2 gene  was  fused  to the E.  coli trpE gene,  permitting 
production of a fusion protein containing 70 kD of SPA2 and 
37  kD  of trpE  sequence.  The  fusion  protein  was overpro- 
duced in E. coli and high titer polyclonal antibodies prepared 
(Fig. 3 B). Affinity-purified antibodies specific for the SPA2/ 
trpE fusion protein were prepared as described in the Mate- 
rials and Methods section. These affinity-purified antibodies 
react  strongly  with  the  /3-gal  fusion  Proteins  encoded  by 
hSPA2.3 and  XSPA2.4, but  do  not  react  with  either  SPA1/ 
~-gal fusion proteins  or E.  coli proteins  (see Fig.  3  C). 
Immunoblots of total yeast cellular proteins were probed 
with affinity-purified anti-SPA2 antibodies. As shown in Fig. 
4, a yeast protein of ,x,180 kD molecular mass is recognized 
by the antibody probe. Several minor species of lower molec- 
ular mass are also detected;  we suspect that these are likely 
to be degradation products as their presence diminishes un- 
der conditions that reduce proteolysis. The 180-kD polypep- 
tide (and any minor proteins) is not observed in similar pro- 
tein samples prepared from a spa2 mutant strain, spa2-A1, 
which  is viable (see below).  Thus,  the SPA2 gene encodes 
the  180-kD polypeptide. 
The SPA2 Gene Product Localizes to the Site of 
Bud Growth 
Affinity-purified  anti-SPA2  antibodies  were  next  used  as 
probes for indirect immunofluorescence using either a-cells, 
t~-cells,  or a/ct-diploids.  In budded  cells of all three types, 
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yeast  cellular  proteins  probed 
with  afffinity-purified anti-SPA2 
antibodies.  Total yeast  cellular 
proteins were prepared from strain 
Y549 (wild-type) and Y550 (spa2 
mutant),  and  separated  on  a 5- 
16% gradient polyacrylamide gel 
containing  SDS. Proteins  were 
blotted to nitrocellulose and probed 
with  affinity-purified  anti-SPA2 
antibodies.  Comparable  results 
were  found using  strains  Y551 
and Y548. 
the SPA2 antigen is localized to a crescent at the tip of the 
bud, and in unbudded cells to a sharp crescent at one edge 
of the cell (Fig. 5, A, C, and D). No such staining is observed 
when either preimmune serum is used (not shown) or spa2 
mutant cells are used (Fig.  5 F). 
Immunofluorescence experiments were also performed on 
cells whose growth was arrested with mating factors, a-Cells 
were treated with c~-factor so that >95 % of the cells arrested 
as unbudded cells; these cells were then probed with anti- 
SPA2  antibodies.  The SPA2  antigen localized as a crescent 
at one apex of the cells as had been found for unbudded cells 
(Fig. 5 E). Moreover, many of the cells (40%) had acquired 
the pear-shaped cell morphology characteristic of"schmoos'; 
in these cells the SPA2 antigen localized to a crescent at the 
schmoo tip. The SPA2 reactivity was not seen in control ex- 
periments using  isogenic a-spa2 mutant cells treated  with 
a-factor and was not present when preimmune serum was 
used (data not shown).  A  culture containing a-cells mixed 
with  ct-cells  was  also  used  for  immunofluorescence  with 
anti-SPA2 antibodies. Schmoos identified in this culture also 
stained  the  schmoo  tip  as  before.  In  addition,  budding 
zygotes showed staining at the tip of the newly formed bud. 
Thus, the SPA2 antigen localizes to a discrete site in growing 
and arrested cells and in all cell types. 
Localization of the SPA2 Antigen in spal Mutant Cells 
The SPAI gene of yeast was isolated with human anti-spindle 
pole autoantibodies and is involved in chromosome segrega- 
tion and mitotic functions (Snyder and Davis, 1988). A large 
fraction of  the population of spal mutant cells (15-30 %) con- 
tain  more  than  one  nucleus.  When  anti-SPA2  antibodies 
were used to probe spal mutant cells, a staining pattern simi- 
lar to that of wild-type cells was seen; in budded cells a cres- 
cent at the tip of the bud is observed, and in unbudded cells 
a crescent is found on one edge of the cell. However, ~10% 
of the cells that contain a single nucleus have more than one 
SPA2-1ocalizing crescent (Fig. 5  G). In cells with multiple 
nuclei, >80%  show aberrant SPA2  labeling; either a  single 
enlarged crescent was seen or the numbers of crescents and 
nuclei were equal.  For example, Fig.  5 I  shows a cell with 
an apparently enlarged crescent, but careful inspection sug- 
gests that two crescents are present:  one crescent is appar- 
ently  half the  size of a  wild-type cell  crescent,  while the 
other is  1.5  times as large.  Cells with multiple nuclei and 
SPA2 localization sites always have an equivalent number of 
spindle  poles as  determined  using double  immunofluores- 
cence experiments with a human anti-microtubule antibody 
(Fig. 5 K; Snyder and Davis, 1988). Thus, spa1 mutant cells 
exhibit alterations in the number and size of the SPA2-con- 
taining crescents, and in cells with multiple nuclei the num- 
ber or size of the crescents correlates with the number of 
nuclei. 
Disruption of the SPA2 Gene In lOvo 
To investigate the function of the SPA2 gene in vivo, disrup- 
tion mutations were created by two different methods. Two 
mutant alleles, spa2-7 and spa2-8,  contain insertion muta- 
tions; these mutations were constructed in E. coli using mini- 
Tnl0  transposable  elements  that  contain  the  URA3 gene 
(Snyder et al.,  1986;  Fig. 6). Subsequently, a large deletion 
allele,  spa2-A1,  was  constructed  by  substituting  a  DNA 
fragment containing the TRP1 gene for a 2.2-kb internal seg- 
ment of SPA2. These alleles were transformed into diploid 
yeast cells. 
When diploid strains heterozygous for spa2-7, spa2-8,  or 
spa2-A1  were  sporulated,  the  internal  marker (URA3 or 
TRPI)  segregated  2+/2 -  and  haploid spa2  mutant progeny 
were  recovered at  the  same  frequency  as  SPA2 wild-type 
cells, spa2 mutant colonies are equal in size to those of wild- 
type, and spa2 cultures double in optical density at the same 
rate as wild-type cultures in rich media.  Average cell divi- 
sion times are similar between spa2 mutant and wild-type 
cells.  Haploid spa2 mutants mate well.  Diploid spa2/spa2 
mutants  complete  meiosis  successfully  forming  asci  with 
four spores (see Discussion),  and the spore viability is the 
same as for wild-type cells. Thus, spa2 mutants appear simi- 
lar in many respects to wild-type cells. 
However, several phenotypes of spa2 mutants can be ob- 
served; these phenotypes are similar, though not identical, 
for the spa2-7, spa2-8,  and spa2-A1 alleles. All of the spa2 
mutants have a higher proportion of budded cells than iso- 
genie wild-type strains (88 vs. 74%  for spa2-7; see below 
and Table III), and occasionally, cells with deformed buds 
are seen in growing cultures, spa2 mutant cells often appear 
slightly smaller and rounder than isogenic wild-type cells. 
These phenotypes indicate that SPA2 may play a role in the 
regulation of budding. 
spa2 Mutants Have Slightly Altered Budding Patterns 
spa2  mutants were next tested  for defects in  budding  pat- 
terns. Individual cells were chosen from exponentially grow- 
ing  cultures  by micromanipulation and  the  pattern of bud 
emergence in each growing cell was observed (see Materials 
and Methods).  As described above, wild-type haploid cells 
exhibit an axial budding pattern; i.e., the new bud forms ad- 
jacent to the old bud site. This process is very accurate for 
mother cells; 124/124  cells underwent axial budding (Fig. 7; 
Table III). spa2 mutant cells, however, occasionally deviate 
from this pattern;  3-15%  of spa2-7, spa2-8, and spa2-A1 
haploid cells budded further than 90 ° from the old bud site. 
For daughter  haploid cells  similar results  were observed; 
however, even in wild-type cells the accuracy of axial bud- 
ding was reduced (see Materials and Methods). 
For diploid cells the effect of the spa2 mutation is much 
more pronounced, and the result varies slightly with the par- 
ticular spa2 allele.  78%  of wild-type mother cells undergo 
an axial budding pattern. In contrast, diploid spa2-7/spa2-7 
Snyder Yeast  SPA2 Protein  Localizes  to Sites of Cell Growth  1423 Figure 5.  Immunofluorescence of yeast cells using anti-SPA2 afffinity-purified  antibodies.  Indirect immunofluorescence  was carried out 
as described in Materials and Methods; detection of bound antibodies was with fluorescein-conjugated  second antibody probes. Cells were 
simultaneously stained with Hoechst  33258 to visualize the nucleus.  (A) Diploid yeast cells (Y270) stained with anti-SPA2 antibodies. 
Greater than 80%  of the unbudded cells show crescent labeling with these antibodies.  (B)  Hoechst  stain of same sample.  (C) Higher 
magnification of diploid cells stained with anti-SPA2 antibodies.  (D and E) Haploid a-cells (Y133) treated  with anti-SPA2 antibodies. 
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Figure 6. Location of the spa2 insertion mutations and deletion mu- 
tation. Transplason insertion mutations containing the URA3 gene 
in a mini-Tnl0 transposon  were generated  in XSPA2.2 and  sub- 
stituted into the yeast genome to produce the indicated spa2-7 and 
spa2-8 alleles. The position of the insertions are indicated by the 
shaded triangles. The spa2-A1 allele was constructed by substitu- 
tion of a 1.4-kb TRP1 DNA fragment for the internal 2.2-kb Sph 
I fragment of SPA2. 
mothers appear to bud randomly, so that only 46 % bud <90 ° 
from the  previous bud  site and  54%  bud  >90 °  from the 
previous bud position.  Diploid spa2-A1/spa2-A1  mothers 
exhibit a reduced frequency of axial budding such that 62 % 
bud <90 ° from the previous bud site.  For diploid daughter 
cells,  polar  budding  appears  unaffected  and  perhaps  is 
slightly increased by the presence of the spa2 mutations (Fig. 
7). Thus, SPA2 is important for the direction of mother bud 
formation; haploid spa2 mutants exhibit a minor defect in ax- 
ial budding, while diploid mutants are more severely altered 
in this pattern. 
spa2 Mutants Exhibit Defects in Cell Cycle Arrest 
Under Nutrient-limiting Conditions 
Another phenotype of spa2 mutants is an inability to arrest 
properly upon nutrient-limiting conditions. Isogenic spa2-7~ 
spa2-7 and wild-type diploid cultures were grown for 1, 2, 
or 3 d in rich medium, and the percentage of cells that con- 
rained buds  was determined (Table IV). spa2-7 and wild- 
type cell cultures were similar in both optical density and cell 
density at each time point. However, wild-type cells quickly 
stopped budding as the cultures became saturated, with only 
27 % of the cells containing buds after 27 h. In contrast, 60 % 
of spa2-7 cells remained budded. After 3 d, most spa2 cells 
were unbudded, although the fraction containing buds (29 %) 
was still higher than that of wild-type cells (17 %). Interest- 
ingly, in cultures grown for either  1, 2, or 3 d, 36, 37, and 
58%,  respectively,  of the  budded  spa2-7 cells  contained 
multiple buds, some possessing as many as six. Examples of 
cells with multiple buds are shown in Fig.  8.  Under these 
conditions <10% of budded wild-type cells contained more 
than one bud. 
Table IlL Effect of the spa2 Mutations on Budding Patterns 
<90  °  >90 °  R 
Haploid Mothers 
wild-type  100  0  1.00 
spa2- 7  90  10  0.80 
spa2-8  93  7  0.86 
spa2-A 1  97  3  0.94 
Haploid Daughters 
wild-type  73  27  0.46 
spa2-7  69  31  0.38 
spa2-8  63  37  0.26 
spa2-A 1  63  37  0.26 
Diploid Mothers 
wild-type  78  22  0.56 
spa2-7  47  53  -0.06 
spa2-A1  62  38  0.24 
Diploid  Daughters 
wild-type  20  80  -0.60 
spa2-7  ! 1  89  -0.78 
spa2-A 1  18  82  -  0.64 
Effect of the spa2 mutations on budding patterns.  The percentage of cells that 
budded <90 ° and >90 ° was determined as described in Fig. 7. As an additional 
means of analyzing these data, R values were calculated whereby R =  [(n of 
divisions <90 °) -  (n of divisions >90°)]/(total  n of divisions). Thus 100% axi- 
al budding would yield R =  1.0, random budding would result in R =  0.00, 
and  100% polar budding would yield R =  -  1.0. This system of analysis is 
derived  from that described  for Drosophila olfaction assays (Rodrigues and 
Siddiqui,  1978). 
As an alternative assay for entry into stationary phase, the 
resistance of spa2  mutants  to  heat  shock was  tested  (see 
Whiteway  and  Szostak,  1985).  Logarithmically  growing 
yeast cells die when suddenly exposed to high temperatures, 
but cells  in  stationary phase are  resistant  (Table IV).  Ex- 
ponentially growing cultures of spa2-7, spa2-A1, and wild- 
type diploid cells were incubated for 0,  1, 2, or 3 d as de- 
scribed above and briefly shifted to 54.5°C.  The frequency 
of viable cells was then determined relative to that of cells 
that did not receive a heat shock.  For each time point, the 
percentage of spa2 mutant cells that survived the heat shock 
was less than that of wild-type cells (Table IV). For example, 
in wild-type cultures after 3 d of growth, 70%  of the cells 
were  resistant  to  heat  shock;  however,  in  spa2-7 mutant 
strains only 39%  were resistant.  Thus, spa2 mutants often 
have problems entering stationary phase under nutrient-lim- 
iting  conditions,  and  many spa2-7 cells accumulate more 
than one bud under these conditions. 
Discussion 
A  gene was isolated from S.  cerevisiae using human anti- 
spindle pole antibodies and named SPA2. SPA2 may play an 
important role in bud formation and cell growth. Consistent 
with this suggestion, the SPA2 protein localizes to the site of 
In E, the a-cells had been arrested with ct-factor. (F) spa2-7 homozygous diploids stained with anti-SPA2 antibodies, spa2 mutant cells 
are typically slightly smaller than that of wild-type cells; this experiment shows an extreme example. (G and I) spa1-1 homozygous diploid 
cells (Y376) stained with anti-SPA2 antibodies. Note the double crescent in G and enlarged crescent in 1, respectively. (H and J) Hoechst 
stains of the same samples. For the cell shown in G, the mitochondria are near the crescents. (K) Anti-microtubule  stain of the sample 
in ! and J detected with rhodamine probes. The two arrays of microtubules were not in the same plane of focus, and a best-attempt photograph 
is presented.  Bars:  (A, B, and F) ,'o15/~m; (C-E and G-K) ~6 I~m. 
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Figure 7. Direction of budding of spa2 mutant and wild-type cells. The budding pattern of new mother cells and daughter cells was deter- 
mined by observation of individual cell growth on plates using a  dissection microscope (see Materials and Methods). The direction of 
the new bud was determined relative to the old bud site for each cell. The ordinate refers to the percentage of yeast cells that exhibit the 
pattern indicated on the axis. For simplicity, the results are presented as <90 ° or >90°;  subdivision of the budding patterns into 45 ° or 
60  °  intervals yields similar conclusions.  The number of cell divisions observed was  118-184 (mean  137).  See also Table HI. 
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Survival after heat shock 
Budded cells  Experiment  1  Experiment 2 
Hours  spa2-7  Wild-type  spa2-7  Wild-type  spa2-A1  Wild-type  Days 
0  88  74  0.01  0.0!  0.01  0.02  0 
27.5  60  27  9.0  18  7.7  13.5  1 
47  34  27  34  55  22  42  2 
71  29  17  39  69  35  84  3 
nt  nt  nt  nt  42  92  4 
Tests for entry of spa2 cells into stationary phase, spa2-7(Y457) and wild-type 
(Y270) diploid cells were grown logarithmically in YPD diluted to OD (600) = 
0.025  and incubated for 0, 27.5,  47,  or 71  h without dilution (Budded cells). 
At each time point the OD (600) was slightly higher (8-20%) for the spa2 mu- 
tant cultures relative to wild-type cultures. The percentage of spa2-7 and wild- 
type cells that contained buds was scored by light microscopy (190-400  cells 
were scored at each interval).  In similar experiments with spa2-A1  cells,  the 
percentage of budded cells resembles that of wild-type cells. Aliquots of cells 
were diluted  to 0.5  ×  106 ceUs/ml and  subjected to a 5-min heat shock  at 
54.5°C. Aliquots were plated in duplicate on YPD plates and the number of 
viable cells determined relative to an untreated sample. For Experiment 1, the 
time points were as described above, nt, not tested. For Experiment 2, the time 
points were 0, 26, 50, 74, and  103 h (for each sample 211-1,166  viable colo- 
nies were scored.  Mean, 435). 
bud growth in budding cells, and to a discrete crescent on 
the edge of unbudded cells. In unbudded cells SPA2 may 
mark the site where bud formation will occur; the SPA2 pro- 
tein resides at one end of  the cell, and in a-cells arrested with 
a-factor the SPA2 crescent is found at the schmoo tip. The 
schmoo tip has been reported as the site of bud formation 
upon hormone removal (for example, see Holm et al., 1985). 
Actin is also in these regions in budded and unbudded cells, 
but with a  pattern very different from SPA2  (Adams and 
Pringle,  1984;  Kilmartin and Adams,  1984). 
Mutations were constructed in the SPA2 gene using trans- 
plason insertions (Snyder et al.,  1986)  and standard dele- 
tion-substitution methods. These mutations are still capable 
of making truncated spa2 polypeptides and are not necessar- 
ily null mutations. Assuming 180 kD is a reasonable size es- 
timate of the primary SPA2  translation product, then the 
maximum amount of functional SPA2 coding sequence 5' to 
the  disruption is  ~1.5,  1.9, and 3.3  kb for the spa2-A1, 
spa2-7, spa2-8 alleles, respectively. Thus, for spa2-A1 the 
maximum size of any truncated polypeptide is expected to be 
less than one third the length of the wild-type gene product. 
spa2 mutants are viable but exhibit defects in budding and 
in the control of cell growth.  Under nutrient-limiting con- 
ditions, spa2 cells have difficulty entering into stationary 
phase,  and spa2-7 cells  synthesize multiple buds.  In  ex- 
ponentially growing cultures occasional cells are observed 
that have deformed buds. spa2 mutants are typically slightly 
smaller and rounder than their wild-type counterparts, and 
a higher fraction of spa2 mutants cells are budded. Pheno- 
types involving budding and growth control are not unex- 
pected from mutagenesis of a single gene, because bud for- 
mation is linked with initiation of a new cell cycle, and these 
events are presumably coordinately controlled. Therefore, 
defects in either pathway, budding or cell cycle control, may 
directly or indirectly perturb the other pathway. 
Impaired entry into stationary phase is a phenotype spa2 
mutants share with ardl and bey1 mutants, although the de- 
fect appears to be a more severe for ardl and bey1 cells than 
for spa2 mutants. The BCY1 gene encodes the regulatory 
subunit of cAMP-dependent protein kinase, and the ARD1 
gene encodes a potential DNA-binding protein with some 
sequence  similarity to the homeobox (Toda  et al.,  1985; 
Whiteway and Szostak, 1985). At present, the gene products 
acted upon by the cAMP-dependent protein kinase and ARD1 
protein  are unknown.  It will be  interesting to determine 
whether the SPA2, ARD1, and BCY1 proteins all operate in 
the same pathway. Like ardl and bey1 mutants, spa2-A1 mu- 
tants typically form fewer four-spored tetrads than wild-type 
cells (data not shown). Interestingly, spa2 tetrads that have 
formed frequently contain a bud adjacent to the ascus sug- 
gesting that they have undergone meiosis before the proper 
arrest of mitotic cell growth. 
In addition to a role in cell cycle control, SPA2 affects the 
budding pattern of yeast cells, spa2  mutants sometimes devi- 
ate from the expected axial budding pattern in haploids. In 
diploids, spa2  mother cells exhibit a reduced fidelity of axial 
budding;  in  fact, spa2-7 mutants bud randomly. Thus,  a 
SPA2-dependent mechanism must affect the fidelity of axial 
budding of diploid mother cells. In spa2 diploids, the polar 
budding pattern of daughter cells is not disturbed. The effect 
of the spa2 mutation may be to impair the overall fidelity of 
axial budding.  Because the efficiency of axial budding in 
mothers is poor in diploid ceils relative to haploid cells (78 
vs.  100%,  respectively), the defect may therefore appear 
more pronounced in diploids. 
In general, the budding defects of spa2-7 mutants appear 
stronger than those of spa2-A1 cells. It is therefore possible 
that a residual spa2-7  gene product may interfere with nor- 
mal budding functions. 
The protein encoded by SPA2  is antigenically related to the 
mammalian spindle pole; the significance of this observation 
is unclear. The SPA2 protein may fortuitously  contain an epi- 
tope cross-reactive with the mammalian spindle pole. This 
epitope is probably not frequently recognized by anti-spin- 
dle pole autoantibodies because only one of four sera tested 
reacted with SPA2 Xgtll clones (Snyder and Davis,  1988). 
An alternative, but potentially more interesting, possibility 
is that SPA2 may be involved in microtubule capture. In yeast 
cells,  double immunofluorescence experiments with anti- 
microtubule and anti-SPA2 antibodies indicate that the SPA2 
crescent usually resides on the same side of the nucleus as 
the spindle pole; this configuration would be expected if the 
SPA2 protein were at one end of the cytoplasmic microtubule 
bundle  (Byers,  1981). In  cells  that  do  contain  long  ex- 
tranuclear microtubule bundles, the distal end of the bundle 
(the presumed plus end) is always observed to intersect the 
SPA2 crescent (Page, B., and M. Snyder, unpublished obser- 
vations).  That  SPA2-related  polypeptides  interact  either 
directly or indirectly with microtubules in other eukaryotes 
is suggested by the fact that, in frog neurons, anti-SPA2 anti- 
bodies react well with a protein in neurites (Snyder, M., un- 
published observations); neurites contain copious amounts 
of microtubules. 
In spa1 mutant cells with multiple nuclei, the number of 
SPA2 crescents correlates with the number of nuclei present. 
It is possible that the number of nuclei (and perhaps spindle 
poles) directly or indirectly determines the number of SPA2 
crescents. The SPA2 patches could in turn affect the number 
Snyder  Yeast  SPA2 Protein Localizes to Sites of Cell Growth  1427 Figure 8. spa2-7  mutant cells often contain multiple buds under nutrient-limiting conditions, spa2-7/spa2-7  (Y457) and wild-type (Y270) 
diploid cells were grown 2Z.5 h in YPD media and viewed using Nomarski interference microscopy. 
of buds formed since spa1 mutant cells that contain multiple 
nuclei often contain multiple buds (Snyder and Davis, 1988). 
Attempts to make spal/spa2 double mutants through sim- 
ple  genetic crosses  have been unsuccessful.  Diploid  cells 
heterozygous or homozygous for the spa1 mutation sporulate 
well, as do spa2 diploids. However, spal/spa2 double hetero- 
zygotes rarely form four-spored tetrads. The sporulation de- 
fect of spal/spa2 double heterozygotes suggests  that  both 
genes may be involved in similar pathways or similar func- 
tions. 
The SPA2 protein localizes to sites of  yeast cell growth and 
plays a role in determining the direction of cell division. The 
CDC24 gene product of yeast is also involved in bud forma- 
tion and in establishing the direction of cell growth (Sloat et 
al., 1981). J. Chant and I. Herskowitz (personal communica- 
tion) have identified five additional genes important for di- 
recting axial budding in haploid yeast cells. Further analysis 
of yeast genes involved in polarized growth and division may 
allow  an  understanding  of the  molecular  mechanisms  by 
which eukaryotes carry out these fundamental processes. 
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